Terms: = Leukemia AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Treatment
365 results:
1. Prognostic impact of clonal hematopoiesis mutations at complete molecular remission in acute myeloid leukemia with NPM1 mutation.
Wang L; Shu M; Zhang Z; Dou X; Xu X; Ma Y; Wen L; Yang X; Chen S
J Cancer Res Clin Oncol; 2024 Oct; 150(10):465. PubMed ID: 39422784
[TBL] [Abstract] [Full Text] [Related]
2. Cannabinoid combination targets
Besser E; Gelfand A; Procaccia S; Berman P; Meiri D
Elife; 2024 Sep; 12():. PubMed ID: 39258755
[TBL] [Abstract] [Full Text] [Related]
3. Ibrutinib plus rituximab and mini-chop in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.
Verner E; Johnston A; Pati N; Hawkes EA; Lee HP; Cochrane T; Cheah CY; Filshie R; Purtill D; Sia H; Enjeti AK; Brown C; Murphy N; Curnow J; Lee K; Gandhi MK; Walia M; Butcher BE; Trotman J
Blood Adv; 2024 Nov; 8(21):5674-5682. PubMed ID: 39226464
[TBL] [Abstract] [Full Text] [Related]
4. [Antibody-Drug Conjugate for Treating leukemia and Lymphoma-The Present Status, Problems, and Future Development].
Ida N; Yamauchi T
Gan To Kagaku Ryoho; 2024 Jul; 51(7):686-690. PubMed ID: 39191681
[TBL] [Abstract] [Full Text] [Related]
5. Blinatumomab after R-chop bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
Guièze R; Ysebaert L; Roos-Weil D; Fornecker LM; Ferrant E; Molina L; Aurran T; Clavert A; de Guibert S; Michallet AS; Saad A; Drénou B; Quittet P; Hivert B; Laribi K; Gay J; Quinquenel A; Broseus J; Rouille V; Schwartz D; Magnin B; Lazarian G; Véronèse L; de Antonio M; Laurent C; Tournilhac O; Pereira B; Feugier P
Nat Commun; 2024 Aug; 15(1):6822. PubMed ID: 39122717
[TBL] [Abstract] [Full Text] [Related]
6. Proteasome inhibition induces apoptosis through simultaneous inactivation of MCL-1/BCL-XL by NOXA independent of chop and JNK pathways.
Chen W; Sun M; Sun Y; Yang Q; Gao H; Li L; Fu R; Dong N
Toxicology; 2024 Nov; 508():153906. PubMed ID: 39117261
[TBL] [Abstract] [Full Text] [Related]
7. [Melatonin Enhances the Effect of ABT-737 in Acute Monocytic leukemia THP-1 Cells].
Lomovsky AI; Baburina YL; Fadeev RS; Kobyakova MI; Lomovskaya YV; Krestinin RR; Sotnikova LD; Krestinina OV
Mol Biol (Mosk); 2024; 58(1):141-153. PubMed ID: 38943585
[TBL] [Abstract] [Full Text] [Related]
8. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; Hänel M; Dierlamm J; Pott C; Klapper W; Gözel D; Schmidt C; Unterhalt M; Ladetto M; Hoster E
Lancet; 2024 May; 403(10441):2293-2306. PubMed ID: 38705160
[TBL] [Abstract] [Full Text] [Related]
9. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
10. CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma.
Xu X; Zhang Y; Lu Y; Zhang X; Zhao C; Wang J; Guan Q; Feng Y; Gao M; Yu J; Song Z; Liu X; Golchehre Z; Li L; Ren W; Pan-Hammarström Q; Zhang H; Wang X
Cancer Res; 2024 Jul; 84(13):2123-2140. PubMed ID: 38635903
[TBL] [Abstract] [Full Text] [Related]
11. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
Hampel PJ; Swaminathan M; Rogers KA; Parry EM; Burger JA; Davids MS; Ding W; Ferrajoli A; Hyak JM; Jain N; Kenderian SS; Wang Y; Wierda WG; Woyach JA; Parikh SA; Thompson PA
Blood Adv; 2024 May; 8(10):2342-2350. PubMed ID: 38537065
[TBL] [Abstract] [Full Text] [Related]
12. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic Modulation of ddit3 and MGMT Expression Acts Synergistically with Resistance to Imatinib towards CML Disease Progression: A Hospital based Study.
Hazarika G; Kalita MJ; Kalita S; Das PP; Dutta K; Lahkar L; Rajkonwar A; Idris MG; Khamo V; Kusre G; Medhi S
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4059-4069. PubMed ID: 38156838
[TBL] [Abstract] [Full Text] [Related]
14. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study.
Hekmatshoar Y; Rahbar Saadat Y; Ozkan T; Bozkurt S; Karadag Gurel A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(7):664-684. PubMed ID: 38117080
[TBL] [Abstract] [Full Text] [Related]
15. Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
Häselbarth L; Gamali S; Saul D; Krumbholz M; Böttcher-Loschinski R; Böttcher M; Zou D; Metzler M; Karow A; Mougiakakos D
BMC Cancer; 2023 Nov; 23(1):1153. PubMed ID: 38012567
[TBL] [Abstract] [Full Text] [Related]
16. SOHO State-of-the-Art Updates and Next Questions: treatment for Newly Diagnosed Peripheral T-Cell Lymphomas.
Burton JS; Foley NC; Mehta-Shah N
Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):65-76. PubMed ID: 37973458
[TBL] [Abstract] [Full Text] [Related]
17. [Adult T-cell leukemia/lymphoma].
Yoshimitsu M
Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
[TBL] [Abstract] [Full Text] [Related]
18. Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-chop pathway.
Hua L; Yang N; Li Y; Huang K; Jiang X; Liu F; Yu Z; Chen J; Lai J; Du J; Zeng H
Br J Haematol; 2023 Sep; 202(5):971-984. PubMed ID: 37409755
[TBL] [Abstract] [Full Text] [Related]
19. The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma.
Roh J; Pak HK; Jeong S; Hwang S; Kim DE; Choi HS; Kim SJ; Kim H; Cho H; Park JS; Jeong SH; Choi YS; Han JH; Yoon DH; Park CS
Biochem Biophys Res Commun; 2023 Sep; 673():36-43. PubMed ID: 37356143
[TBL] [Abstract] [Full Text] [Related]
20. Melatonin Can Enhance the Effect of Drugs Used in the treatment of leukemia.
Lomovsky AI; Baburina YL; Fadeev RS; Lomovskaya YV; Kobyakova MI; Krestinin RR; Sotnikova LD; Krestinina OV
Biochemistry (Mosc); 2023 Jan; 88(1):73-85. PubMed ID: 37068876
[TBL] [Abstract] [Full Text] [Related]
[Next]